Nantahala Capital Management »

Kintara Therapeutics shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Kintara Therapeutics (KTRA) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Kintara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kintara Therapeutics held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kintara Therapeutics by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.3k 13k 0.10
2023-12-31 $3.7k 22k 0.17
2023-09-30 $91k 23k 4.04
2022-12-31 $82k 12k 6.89

More positions owned by Nantahala Capital Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Spdr Ser Tr S&p Biotech (XBI)
Establishment Labs Holdings Ord (ESTA)
Soleno Therapeutics (SLNO)
Eli Lilly & Co. Put Option (LLY)
Grand Canyon Education Put Option (LOPE)
Meta Financial (CASH)
Costco Wholesale Corporation Put Option (COST)
Evolus (EOLS)
Peloton Interactive Cl A Com (PTON)
Imax Corp Cad (IMAX)
Hilton Grand Vacations (HGV)
Bioventus Com Cl A (BVS)
Rumbleon Com Cl B (RMBL)
Ishares Tr U.s. Real Es Etf Put Option (IYR)

View all positions for Nantahala Capital Management

Top funds holding Kintara Therapeutics

UBS Group
Susquehanna International
Hrt Financial
Jane Street
Geode Capital Management
Tower Research Capital
Nantahala Capital Management
Vanguard Group
Qube Research & Technologies
Advisor Group Holdings
Acadian Asset Management
Wells Fargo & Company

View all funds holding Kintara Therapeutics